- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT05967195
Versuch zur Erhöhung der FEP-Teilnahme
Finanzielle Anreize zur Erhöhung der Behandlungsteilnahme bei der Behandlung von Psychosen in der ersten Episode: Eine nicht randomisierte, adaptive Pilotstudie
Individuals with first-episode psychosis (FEP) are at high-risk for several poor functional and clinical outcomes, including suicide. Coordinated Specialty Care (CSC) is a multidisciplinary, team-based intervention known to improve such outcomes, including suicide risk. However, 30-50% of patients disengage from CSC, thereby limiting its impact. This pilot study will develop and test feasibility of a behavioral change program that uses moderate financial incentives to encourage treatment engagement in 2 CSC programs. A single-arm of 80 patient-participants at these two clinics will be recruited to assess feasibility and acceptability from patient perspectives. Additionally,15 clinicians at these two clinics will be recruited to assess feasibility and acceptability from clinician perspectives, and 50 clinicians from peer clinics not involved in the intervention will be recruited to assess scalability of the intervention. The trial will feature an three-month period for recruitment and baseline data collection and will subsequently feature three intervention periods (3 months each) where modifications to the interventions will be tested (each informed by the feasibility and acceptability findings of the prior period) with the aim of sequentially improving it.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Studientyp
Einschreibung (Geschätzt)
Phase
- Frühphase 1
Kontakte und Standorte
Studienorte
-
-
North Carolina
-
Raleigh, North Carolina, Vereinigte Staaten, 27608
- University of North Carolina at Chapel Hill (ENCOMPASS Program)
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Vereinigte Staaten, 19123
- PEACE Program, Horizon House, Inc.
-
Philadephia, Pennsylvania, Vereinigte Staaten, 19104
- University of Pennsylvania
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- For all participants, age ≥ 18 years old.
- For intervention trial and patient feasibility and acceptability measurement: Patients with first-episode psychosis, enrolled in Coordinated Specialty Care at the Psychosis Education, Assessment, Care and Empowerment (PEACE) clinic and Psychosis Evaluation and Recovery Center (PERC).
- For clinician feasibility and acceptability measurement at intervention sites: Clinicians working at PEACE and PERC where the intervention will be piloted.
- For clinician implementation facilitator and barrier assessment at other Connection LHS sites to assess for scalability: Clinicians in Connection LHS who work at sites other than PEACE and PERC.Participants must sign the informed consent form
Exclusion Criteria:
- For intervention trial and patient feasibility and acceptability measurement: Expectation of leaving coordinated specialty care programing within 6 months (which will exclude all of the PI's patient panel) and/or intellectual disability of sufficient degree that the patient's primary psychiatrist expects to compromise capacity to consent to this research and/or psychosis secondary to another medical condition (which may not share the same motivational features that are otherwise understood about the primary psychiatric conditions with psychosis).
- For clinician feasibility and acceptability measurement at intervention sites: Study investigators who work at these clinics will be excluded from participation in the feasibility and acceptability study component given their role in the trial planning and execution.
- For clinician implementation facilitator and barrier assessment at other Connection LHS sites to assess for scalability: none.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Nicht randomisiert
- Interventionsmodell: Einzelgruppenzuweisung
- Maskierung: Keine (Offenes Etikett)
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Acceptability of intervention measure (AIM)
Zeitfenster: Change at 8 months
|
The AIM is a 4-item scale measuring acceptability. Each item is scored 1-5 with 5 indicating greater acceptability. Minimum score is 4; maximum is 20. |
Change at 8 months
|
|
Acceptability of intervention measure (AIM)
Zeitfenster: Change at 6 months
|
The AIM is a 4-item scale measuring acceptability. Each item is scored 1-5 with 5 indicating greater acceptability. Minimum score is 4; maximum is 20. |
Change at 6 months
|
|
Acceptability of intervention measure (AIM)
Zeitfenster: Change at 4 months
|
The AIM is a 4-item scale measuring acceptability. Each item is scored 1-5 with 5 indicating greater acceptability. Minimum score is 4; maximum is 20. |
Change at 4 months
|
|
Feasibility of intervention measure (FIM)
Zeitfenster: Change at 8 months
|
The FIM is a 4-item scale measuring feasibility. Each item is scored 1-5 with 5 indicating greater feasibility. Minimum score is 4; maximum is 20. |
Change at 8 months
|
|
Feasibility of intervention measure (FIM)
Zeitfenster: Change at 6 months
|
The FIM is a 4-item scale measuring feasibility. Each item is scored 1-5 with 5 indicating greater feasibility. Minimum score is 4; maximum is 20. |
Change at 6 months
|
|
Feasibility of intervention measure (FIM)
Zeitfenster: Change at 4 months
|
The FIM is a 4-item scale measuring feasibility. Each item is scored 1-5 with 5 indicating greater feasibility. Minimum score is 4; maximum is 20. |
Change at 4 months
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Implementation Survey Response
Zeitfenster: Change at 8 months
|
Implementation survey. Results will be used to optimize intervention from implementation perspective. |
Change at 8 months
|
|
Implementation Survey Response
Zeitfenster: Change at 6 months
|
Implementation survey. Results will be used to optimize intervention from implementation perspective. |
Change at 6 months
|
|
Implementation Survey Response
Zeitfenster: Change at 4 months
|
Implementation survey. Results will be used to optimize intervention from implementation perspective. |
Change at 4 months
|
|
Motivation Survey Response
Zeitfenster: Change at 8 months
|
Motivation survey. Results will be used to optimize intervention from motivation perspective. |
Change at 8 months
|
|
Motivation Survey Response
Zeitfenster: Change at 6 months
|
Motivation survey. Results will be used to optimize intervention from motivation perspective. |
Change at 6 months
|
|
Motivation Survey Response
Zeitfenster: Change at 4 months
|
Motivation survey. Results will be used to optimize intervention from motivation perspective. |
Change at 4 months
|
|
Ethical Concern Survey Response
Zeitfenster: Change at 8 months
|
Ethical concern survey. Results will be used to optimize intervention from ethical acceptability perspective. |
Change at 8 months
|
|
Ethical Concern Survey Response
Zeitfenster: Change at 6 months
|
Ethical concern survey. Results will be used to optimize intervention from ethical acceptability perspective. |
Change at 6 months
|
|
Ethical Concern Survey Response
Zeitfenster: Change at 4 months
|
Ethical concern survey. Results will be used to optimize intervention from ethical acceptability perspective. |
Change at 4 months
|
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
attrition
Zeitfenster: Change at 8 months
|
rate of attrition |
Change at 8 months
|
|
attrition
Zeitfenster: Change at 6 months
|
rate of attrition |
Change at 6 months
|
|
attrition
Zeitfenster: Change at 4 months
|
rate of attrition |
Change at 4 months
|
|
psychotic symptomology
Zeitfenster: Change at 8 months
|
Compass-10. The Compass-10 is a self-report scale that measures multiple symptoms associated with psychosis, including mood symptoms. It consists of 10-items, each scored 0-6 with a minimum score of 0 and a maximum of 60. A higher score indicates greater symptomology. |
Change at 8 months
|
|
psychotic symptomology
Zeitfenster: Change at 6 months
|
Compass-10. The Compass-10 is a self-report scale that measures multiple symptoms associated with psychosis, including mood symptoms. It consists of 10-items, each scored 0-6 with a minimum score of 0 and a maximum of 60. A higher score indicates greater symptomology. |
Change at 6 months
|
|
psychotic symptomology
Zeitfenster: Change at 4 months
|
Compass-10. The Compass-10 is a self-report scale that measures multiple symptoms associated with psychosis, including mood symptoms. It consists of 10-items, each scored 0-6 with a minimum score of 0 and a maximum of 60. A higher score indicates greater symptomology. |
Change at 4 months
|
|
psychotic symptomology
Zeitfenster: Change at 8 months
|
modified-Colorado Symptom Index. The modified-Colorado Symptom Index is a 14-item, clinician-rated scale with items ranked 0-4. Total minimum score = 0. Total maximum score = 56. A higher score indicates greater symptomology. |
Change at 8 months
|
|
psychotic symptomology
Zeitfenster: Change at 6 months
|
modified-Colorado Symptom Index. The modified-Colorado Symptom Index is a 14-item, clinician-rated scale with items ranked 0-4. Total minimum score = 0. Total maximum score = 56. A higher score indicates greater symptomology. |
Change at 6 months
|
|
psychotic symptomology
Zeitfenster: Change at 4 months
|
modified-Colorado Symptom Index. The modified-Colorado Symptom Index is a 14-item, clinician-rated scale with items ranked 0-4. Total minimum score = 0. Total maximum score = 56. A higher score indicates greater symptomology. |
Change at 4 months
|
|
depression
Zeitfenster: Change at 8 months
|
abbreviated version of the Beck Depression Inventory-II (BDI-II) that has been previously validated (scale, min=0, max=21, higher mean score indicates more severe depressive symptomology) |
Change at 8 months
|
|
depression
Zeitfenster: Change at 6 months
|
abbreviated version of the Beck Depression Inventory-II (BDI-II) that has been previously validated (scale, min=0, max=21, higher mean score indicates more severe depressive symptomology) |
Change at 6 months
|
|
depression
Zeitfenster: Change at 4 months
|
abbreviated version of the Beck Depression Inventory-II (BDI-II) that has been previously validated (scale, min=0, max=21, higher mean score indicates more severe depressive symptomology) |
Change at 4 months
|
|
quality of life
Zeitfenster: Change at 8 months
|
4-item version of the Lehman Quality of Life Scale (min = 4, max =28, higher score is improved quality of life) |
Change at 8 months
|
|
quality of life
Zeitfenster: Change at 6 months
|
4-item version of the Lehman Quality of Life Scale (min = 4, max =28, higher score is improved quality of life) |
Change at 6 months
|
|
quality of life
Zeitfenster: Change at 4 months
|
4-item version of the Lehman Quality of Life Scale (min = 4, max =28, higher score is improved quality of life) |
Change at 4 months
|
|
recovery
Zeitfenster: Change at 8 months
|
5-item version of the Questionnaire about the Process of Recovery (scale, min=5, max=25, higher mean indicates more perceived recovery) |
Change at 8 months
|
|
recovery
Zeitfenster: Change at 6 months
|
5-item version of the Questionnaire about the Process of Recovery (scale, min=5, max=25, higher mean indicates more perceived recovery) |
Change at 6 months
|
|
recovery
Zeitfenster: Change at 4 months
|
5-item version of the Questionnaire about the Process of Recovery (scale, min=5, max=25, higher mean indicates more perceived recovery) |
Change at 4 months
|
|
treatment motivation (intrinsic versus extrinsic)
Zeitfenster: Change at 8 months
|
Treatment Motivation Questionnaire-Revised (TMQ-R). The Treatment Motivation Questionnaire-Revised is a 25-item self-assessment survey that assesses several elements of treatment motivation, each ranked 1-5. It is not a single scale that results in an overall score. Some items suggest greatest motivation at a 5 and least at a 1, but others suggest greatest motivation at a 1 and least at a 5. |
Change at 8 months
|
|
treatment motivation (intrinsic versus extrinsic)
Zeitfenster: Change at 6 months
|
Treatment Motivation Questionnaire-Revised (TMQ-R). The Treatment Motivation Questionnaire-Revised is a 25-item self-assessment survey that assesses several elements of treatment motivation, each ranked 1-5. It is not a single scale that results in an overall score. Some items suggest greatest motivation at a 5 and least at a 1, but others suggest greatest motivation at a 1 and least at a 5. |
Change at 6 months
|
|
treatment motivation (intrinsic versus extrinsic)
Zeitfenster: Change at 4 months
|
Treatment Motivation Questionnaire-Revised (TMQ-R). The Treatment Motivation Questionnaire-Revised is a 25-item self-assessment survey that assesses several elements of treatment motivation, each ranked 1-5. It is not a single scale that results in an overall score. Some items suggest greatest motivation at a 5 and least at a 1, but others suggest greatest motivation at a 1 and least at a 5. |
Change at 4 months
|
|
Perceived coercion
Zeitfenster: Change at 8 months
|
Modified version of the MacArthur Admission Experience Survey (AES). The MacArthur AES was developed as a self-assessment for assessing coercion and pressure during inpatient admission. It was previously modified for assisted outpatient treatment. We have modified it further to a 13-item scale for outpatient treatment generally. Each item is assessed as true or false, where true suggests great perception of pressure or coercion on some items, but less on others. |
Change at 8 months
|
|
Perceived coercion
Zeitfenster: Change at 6 months
|
Modified version of the MacArthur Admission Experience Survey (AES). The MacArthur AES was developed as a self-assessment for assessing coercion and pressure during inpatient admission. It was previously modified for assisted outpatient treatment. We have modified it further to a 13-item scale for outpatient treatment generally. Each item is assessed as true or false, where true suggests great perception of pressure or coercion on some items, but less on others. |
Change at 6 months
|
|
Perceived coercion
Zeitfenster: Change at 4 months
|
Modified version of the MacArthur Admission Experience Survey (AES). The MacArthur AES was developed as a self-assessment for assessing coercion and pressure during inpatient admission. It was previously modified for assisted outpatient treatment. We have modified it further to a 13-item scale for outpatient treatment generally. Each item is assessed as true or false, where true suggests great perception of pressure or coercion on some items, but less on others. |
Change at 4 months
|
|
attendance rate
Zeitfenster: Change over 8 months
|
number of appointments attended in a given period divided by number of appointments scheduled |
Change over 8 months
|
|
attendance rate
Zeitfenster: Change at 6 months
|
number of appointments attended in a given period divided by number of appointments scheduled |
Change at 6 months
|
|
attendance rate
Zeitfenster: Change at 4 months
|
number of appointments attended in a given period divided by number of appointments scheduled |
Change at 4 months
|
Mitarbeiter und Ermittler
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Andere Studien-ID-Nummern
- 2023-03
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .